We are pleased to announce that, as of 2026, Macrogen Europe has signed a new agreement extending and strengthening our collaboration with MSM in Turkey.
MSM has been our official distributor for Sanger sequencing services since March 2020. Under the renewed agreement, MSM will continue to represent Macrogen Europe for all CES (Conventional and Express Sequencing) services in Turkey, including:
- Sanger sequencing
- Customized sequencing
- Identification services
- Fragment analysis
- Oligo synthesis
- Gene synthesis
- RNA synthesis
- Peptide synthesis
As part of this agreement, orders for the above-mentioned services in Turkey will continue to be processed exclusively through MSM accounts.
All existing Turkish client accounts in our system will remain active for administrative purposes; however, ordering for the listed CES services must be placed via MSM.
Please note that NGS services are not affected by this arrangement and will continue to follow the existing ordering procedures.
Clients with existing prepayment balances may continue ordering until their balance is fully utilized. For new prepayments related to CES services, please coordinate directly with MSM. (NGS prepayments remain unchanged.)
For further information, please contact Macrogen Europe or MSM directly.
Macrogen contactinformation:
info@macrogen-europe.com
mazen.sarhan@macrogen-europe.com